P1.13-30 Neutrophil-To-Lymphocyte Ratio as a Prognostic Factor and Its Relationship to NSCLC Patient Outcomes in the REVEL Trial
Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.887
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV